Euglena Co., Ltd. (2931.T)
JPY 440.0
(0.46%)
JPY 440.0
(0.46%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2022 | 34.45 Billion JPY | 81.65% |
| 2021 | 18.96 Billion JPY | 67.84% |
| 2020 | 11.29 Billion JPY | -35.12% |
| 2019 | 17.41 Billion JPY | 41.22% |
| 2018 | 12.33 Billion JPY | 33.22% |
| 2017 | 9.25 Billion JPY | 24.39% |
| 2016 | 7.44 Billion JPY | 110.07% |
| 2015 | 3.54 Billion JPY | 107.63% |
| 2014 | 1.7 Billion JPY | 76.33% |
| 2013 | 967.71 Million JPY | 75.16% |
| 2012 | 552.47 Million JPY | 55.68% |
| 2011 | 354.87 Million JPY | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 Q1 | 8.01 Billion JPY | -13.59% |
| 2023 Q3 | 7.91 Billion JPY | -7.13% |
| 2023 Q2 | 8.52 Billion JPY | 6.32% |
| 2022 Q2 | 8.5 Billion JPY | 5.23% |
| 2022 FY | 34.45 Billion JPY | 81.65% |
| 2022 Q4 | 9.27 Billion JPY | 8.07% |
| 2022 Q3 | 8.58 Billion JPY | 0.93% |
| 2022 Q1 | 8.08 Billion JPY | 0.0% |
| 2021 Q2 | 3.6 Billion JPY | 22.11% |
| 2021 Q3 | 9.18 Billion JPY | 154.88% |
| 2021 Q1 | 2.95 Billion JPY | -8.33% |
| 2021 FY | 18.96 Billion JPY | 67.84% |
| 2020 Q3 | 3.48 Billion JPY | 13.11% |
| 2020 Q2 | 3.07 Billion JPY | 42.85% |
| 2020 FY | 11.29 Billion JPY | -35.12% |
| 2020 Q4 | 3.22 Billion JPY | -7.49% |
| 2020 Q1 | 2.15 Billion JPY | -16.68% |
| 2019 Q1 | 2.55 Billion JPY | -71.73% |
| 2019 FY | 17.41 Billion JPY | 41.22% |
| 2019 Q4 | 2.58 Billion JPY | -17.66% |
| 2019 Q3 | 3.14 Billion JPY | 16.62% |
| 2019 Q2 | 2.69 Billion JPY | 5.46% |
| 2018 Q3 | 2.54 Billion JPY | -22.44% |
| 2018 Q1 | 3.46 Billion JPY | 14.02% |
| 2018 FY | 12.33 Billion JPY | 33.22% |
| 2018 Q4 | 9.03 Billion JPY | 254.62% |
| 2018 Q2 | 3.28 Billion JPY | -5.23% |
| 2017 Q1 | 2.48 Billion JPY | 13.87% |
| 2017 Q4 | 3.03 Billion JPY | 45.56% |
| 2017 FY | 9.25 Billion JPY | 24.39% |
| 2017 Q3 | 2.08 Billion JPY | -16.88% |
| 2017 Q2 | 2.51 Billion JPY | 1.25% |
| 2016 Q1 | 1.72 Billion JPY | 4.09% |
| 2016 FY | 7.44 Billion JPY | 110.07% |
| 2016 Q4 | 2.17 Billion JPY | -3.48% |
| 2016 Q3 | 2.25 Billion JPY | 24.93% |
| 2016 Q2 | 1.8 Billion JPY | 4.82% |
| 2015 Q3 | 1.1 Billion JPY | 21.69% |
| 2015 Q4 | 1.65 Billion JPY | 49.31% |
| 2015 FY | 3.54 Billion JPY | 107.63% |
| 2015 Q1 | 807.81 Million JPY | 12.99% |
| 2015 Q2 | 911.27 Million JPY | 12.81% |
| 2014 Q2 | 446.49 Million JPY | 1.42% |
| 2014 Q4 | 714.96 Million JPY | 58.83% |
| 2014 Q3 | 450.15 Million JPY | 0.82% |
| 2014 Q1 | 440.23 Million JPY | 19.15% |
| 2014 FY | 1.7 Billion JPY | 76.33% |
| 2013 Q1 | 225.57 Million JPY | 17.07% |
| 2013 Q4 | 369.48 Million JPY | 32.07% |
| 2013 Q3 | 279.76 Million JPY | 3.73% |
| 2013 Q2 | 269.7 Million JPY | 19.56% |
| 2013 FY | 967.71 Million JPY | 75.16% |
| 2012 FY | 552.47 Million JPY | 55.68% |
| 2012 Q4 | 192.67 Million JPY | 0.0% |
| 2011 FY | 354.87 Million JPY | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Kitanotatsujin Corporation | 9.38 Billion JPY | -267.17% |
| BEAUTY GARAGE Inc. | 5.8 Billion JPY | -493.974% |
| Axas Holdings Co.,Ltd. | 3 Billion JPY | -1048.232% |
| C.I. Medical Co.,Ltd. | 9 Billion JPY | -282.545% |
| Kao Corporation | 438.95 Billion JPY | 92.151% |
| Niitaka Co., Ltd. | 6.65 Billion JPY | -417.316% |
| Rohto Pharmaceutical Co.,Ltd. | 117.23 Billion JPY | 70.614% |
| Shiseido Company, Limited | 696.62 Billion JPY | 95.054% |
| Lion Corporation | 160.09 Billion JPY | 78.48% |
| Mandom Corporation | 29.51 Billion JPY | -16.747% |
| Ivy Cosmetics Corporation | 1.72 Billion JPY | -1896.786% |
| Milbon Co., Ltd. | 24 Billion JPY | -43.549% |
| Nippon Shikizai, Inc. | 2.31 Billion JPY | -1390.295% |
| Fancl Corporation | 61.61 Billion JPY | 44.089% |
| KOSÉ Corporation | 189.85 Billion JPY | 81.854% |
| Cota Co., Ltd. | 4.25 Billion JPY | -710.038% |
| HABA Laboratories,Inc. | 8.21 Billion JPY | -319.439% |
| C'bon Cosmetics Co.,Ltd. | 6.37 Billion JPY | -440.801% |
| Pola Orbis Holdings Inc. | 119.68 Billion JPY | 71.214% |
| Noevir Holdings Co., Ltd. | 31.54 Billion JPY | -9.233% |
| Adjuvant Holdings Co.,Ltd. | 2.86 Billion JPY | -1103.923% |
| Almado, Inc. | 4.11 Billion JPY | -738.144% |
| I-ne CO., LTD. | 17.86 Billion JPY | -92.846% |
| Premier Anti-Aging Co., Ltd. | 15.96 Billion JPY | -115.851% |
| Liberta Co.,Ltd. | 2.68 Billion JPY | -1184.983% |
| AXXZIA Inc. | 8.57 Billion JPY | -301.894% |
| S.T. Corporation | 15.07 Billion JPY | -128.568% |
| Kobayashi Pharmaceutical Co., Ltd. | 70.59 Billion JPY | 51.198% |
| Earth Corporation | 57.25 Billion JPY | 39.827% |
| Sagami Rubber Industries Co., Ltd. | 1.57 Billion JPY | -2093.349% |
| Asahi Eito Holdings Co.,Ltd. | 1.29 Billion JPY | -2553.295% |
| Ya-Man Ltd. | 18.49 Billion JPY | -86.245% |
| MTG Co., Ltd. | 33.26 Billion JPY | -3.578% |
| TRANSACTION CO.,Ltd. | 4.57 Billion JPY | -652.809% |
| SHOBIDO Corporation | 4.5 Billion JPY | -665.535% |
| Artnature Inc. | 25.01 Billion JPY | -37.725% |
| Pigeon Corporation | 34.72 Billion JPY | 0.792% |
| Unicharm Corporation | 351.52 Billion JPY | 90.199% |
| Paltac Corporation | 53.06 Billion JPY | 35.072% |
| CB GROUP MANAGEMENT Co., Ltd. | 13.78 Billion JPY | -149.924% |